際際滷

際際滷Share a Scribd company logo
Diseases of the Vulva
Diseases of the Vulva
Azza Alyamani
Azza Alyamani
Department
Department
of
of
Obstet. & Gynecol.
Obstet. & Gynecol.
Vulvo-vaginal problems are among 10 leading
disorders encountered by primary care clinicians.
* Benign lesions of the vulva are mentioned in three
categories :
1. Epithelial conditions.
2. Benign neoplastic disorders.
3. Dermatologic disorders.
* VIN
* Cancer vulva
Benign Conditions
of the Vulva
(1) Epithelial Conditions
1) Lichen simplex .
2) Lichen sclerosis.
3) Lichen planus,
erosive lichen planus.
1) Lichen Simplex
 squamous cell hyperplasia 
* it is a local thickening of the epithelium resulting
from a prolonged itching .
* symptoms :
pruritus and pain.
* signs :
white or reddish thickened ,leathery ,raised surface.
usually discrete lesion but may be multiple.
* treatment :
 moderate-strength steroid ointment.
 antipruritic agent.
lichen simplex
2) Lichen Sclerosis
* it is a chronic progressive disease which constrict
and destroy the normal genital anatomy . In the
long term ,labia minora are lost ,labia majora
flatten ,clitoris becomes inverted .
* frequently found on the vulva of postmenopausal
women & can involve all the genital area from
mons to the anal area.
* combinations of lichen sclerosis & epithleal
hyperplasia or carcinoma are possible.
* symptoms:
intense pruritus , dyspareunia and burning pain.
* signs:
thin inelastic atrophic skin ,white with a crinkled ,
tissue paper appearance.
* diagnosis:
multiple biopsies is necessary.
it reveals a thin atrophic epithelium with
inflammatory cells lining the basement
membrane.
* treatment:
 potent topical steroids. 80% of lesions respond.
long term therapy with low potent steroids may
be necessary.
 other local treatments are: esrtogen cream and
anaesthetics.
lichen sclerosis advanced
3) Lichen planus
* it is a purplish ,polygonal papules that may
appear in their erosive form.
* it involve the vulva ,the vagina and the mouth
( vulval  vaginal gingival syndrome ).
* symptoms:
vulval burning , severe dyspareunia when
vaginal stenosis develop in advanced stages.
* treatment:
topical and systemic steroids .
erosive lichen planus lichen planus
of vulva & vagina
(2) Benign Neoplastic condions
1) epidermal inclusion and sebaceous cysts.
2) vulvar varicosities.
3) fibromas and lipomas.
4) clitoromegaly.
1) epidermal inclusion & sebaceous cysts
* they are nontender , mobile , spherical ,slow
growing cysts located below the epidermis.
* sebaceous cysts are firmer bec. they are
filled with dry caseous material.
* treatment :
most of inclusion cysts require no ttt. if they
are asymptomatic, or surgical excision.
2) Vulval Varicosities
Can enlarge especially during pregnancy
to cause discomfort and carry a possible
risks for rupture or thrombosis.
3) Fibromas and Lipomas
Fibromas:
* are the most common benign solid tumors
that arise in the deeper connective tissue
of the vulva.
* they are slow growing 110 cm in diameter,
but may become huge .
Lipomas:
* slow growing tumors composed of adipose
cells.
Vulval Fibroma
4) Clitoromegaly
* may develop after birth in response to
excessive androgen exposure . It is a sign
virillization.
* diagnosed when the clitorial length exceeds
30 mm or the width at the base exceeds
10 mm.
clitoromegaly
( 3) Dermatologic Disorders
1) Psoriasis.
2) Behcet s syndrome.
3) Crohn s disease .
4) Acanthosis nigricans .
1) Psoriasis
appears velvety but lack the characteristic
scaly patches found on the knees & elbows.
2) Behcet s syndrome
* ulcers in the vulval , oral and ocular areas.
* genital lesions can result over time in a scarred
vulva.
* etiology : is unknown.
* diagnosis : based on the concurrence ulcers in
vulva ,mouth & ocular involvement ,the
recurrent nature of the disease and exclusion
of syphilis and Crohns disease.
* treatment : no effective ttt.
oral ulcer vulvar ulcer
Behcet s disease
3) Crohns disease
* vulval ulcers can precede the development
of GIT ulcerations .
* vulval ulcers are slit-like or knife  cut ulcers
with prominent edema. Draining sinuses and
fistulas to the rectum may occur.
4) Acanthosis nigricans
* most commonly found in the axilla or the
nape of the neck then vulva.
* characterized by its darky pigmented
velvety or warty surface .
* etiology : related to insulin resistance.
Vulval Neoplasms
Introduction
* uncommon 5 % of female genital tract malign.
most tumors are squamous cell carcinomas ,may
be melanomas , adenocarcinomas and sarcomas.
* postmenopausal women ,mean age 65 years.
* a history of chronic vulval itching is common.
Epidemiology
Two different etiologic types of vulval cancers :
1. A less common type:
* in younger women .
* related to HPV infection and smoking.
* commonly associated with VIN .
2. The more common type:
* in old women .
* unrelated to HPV infection or smoking.
* concurrent VIN is uncommon.
* long standing lichen sclerosis is common.
5% of patients have +ve serologic tests for
syphilis , lymphogranuloma venereum
and granuloma inguinale.
Vulval Intraepithelial Neoplasia (VIN)
2 types of VIN :
1. squamous cell carcinoma in situ
VIN III or Bowens disease.
2. Adenocarcinoma in situ
VIN III or Pagets disease.
Squamous cell carcinoma in situ:
VIN III ( Bowens disease )
* mean age 45 years.
* symptoms:
50% asymptomatic.
itching is the most common symptom.
* signs:
most lesions are elevated ,white ,red ,pink ,
brown or grey in color.
20% of lesions are warty in appearance.
* diagnosis:
1.careful inspection of the vulva in bright
light and with the aid of a magnifying glass.
2. 5% acetic acid aceto white areas.
* treatment :
1. local superficial excision.
with margins of 5 mm are adequate.
2. skinning vulvectomy in extensive lesions.
3. laser therapy
if lesions involves the clitoris , labia minora
or perineal area.
Adenocarcinoma in situ
VIN III ( Paget s disease )
* occurs in white postmenopausal elderly women.
also occurs in the nipple area of the breast.
* 20% is associated with adenocarcinoma.
* symptoms:
itching and tenderness are common.
* signs:
well demarcated and eczematus with white
plaque like lesions.
* growth may progresses beyond the vulva to the
mons pubis ,buttocks & thighs.
* diagnosis
histologically:
adenocarcinoma in situ characterized by
large ,pale , pathognomonic Paget s cells,
typically located both in the epidermic and
in the adnexal structures.
* treatment:
1. local superficial excision.
with margins 5-10 mm.
2. laser therapy
in recurrences which are common.
Paget s disease
Invasive Cancer Vulva
A. Squamous cell carcinoma
* 90% of vulval cancers.
* symptoms:
 vulval lump or ulcer.
 long standing pruritus.
* signs:
 raised ,ulcerated ,pigmented or warty lesion.
however , ulceration is usually an early sign.
 most lesions occur on labia majora and labia
minora. Less common sites , the clitoris
or the perineum.
 5% of lesions are multifocal.
squamous cell carcinoma of vulva
* spread :
 direct extension
to adjacent structures as the vagina , urethra
and anus.
 lymphatic embolisation
inguino femoral nodes.
= initially to the superficial inguinal LN.
= then to deep femoral LN. located medial
to the femoral vein, LN of Cloquets is
the most common of this group.
=then spread occurs to pelvic nodes
especially the external iliac LN.
= LN metastases occurs 50% in cancer vulva.
5% of patients have metastases to pelvic
LN , usually 3 or more +ve unilateral
inguino femoral LN.
 hematogenous
occurs late to the lungs , liver and bone rarely
in the absence of lymphatic metastases.
FIGO Staging of Cancer Vulva
Stage I
Ia
Ib
Stage II
Stage III
Tumor limited to the vulva or perineum or both ,and
2 cm or < in diameter ,and no nodal metastases.
as above + stromal invasion < 1mm.
as above + stromal invasion > 1 mm.
Tumor limited to the vulva or perineum or both ,and
> 2 cm in diameter ,and no nodal metastases.
Tumor of any size with :
 adjacent spread to the urethra &/or vagina &/or
anus
 unilateral regional LN. metastasis or combination.
Stage IV
IVa
IVb
Tumor invades any of the following pelvic :
upper urethra ,bladder mucosa ,rectal
mucosa ,pelvic bone or bilateral regional
node metastasis ,or a combination.
Any distant metastasis including pelvic
lymph nodes.
Management
A) Early vulval cancer
* Stage I a
( penetration depth < 1mm below the basement
membrane & no nodal metastases )
radical local excision 辿 surgical margins
1cm, patient do not need groin dissection.
* Stage I b & Stage II
( penetration > 1mm )
radical local excision +ipsilateral inguinal
femoral lymphadenectomy if the lesion is
unilateral and bilateral groin dissection in
the midline lesions .
B) Advanced vulval cancer
* Stage III
( involves the proximal urethra ,anus or rectovaginal
septum )
radical vulvectomy which includes a bowel,
urinary stroma or rectovaginal septum.
+ bilateral groin dissection.
Preoperative radiation or chemo-radiation should be
used to shrink the 1ry tumor ,followed by more
conservative surgical excision.
C) Positive lymph nodes
Radiation
used with > one nodal mico metastasis (<5mm),
or evidence of extra nodal spread .
postoperative radiation to both groins
and to the pelvis.
Prognosis:
= it correlate significantly with LN status.
with ve nodes have a 5-ys survival rate is 90%.
with +ve nodes have a 5-ys survival rate is 50%.
= patient with no involved node have a good
prognosis regardless of stage.
Malignant Melanoma
* the 2nd
most common vulvar cancer.
* may arise de novo or from a preexisting nevus.
commonly involve labia minora or clitoris.
* occurs in postmenopausal white women.
* diagnosis :
any pigmented lesion of the vulva requires
excisional biopsy for histopathology.
* usually smaller lesions and tend to metastasized
early.
malignant melanoma of the vulva
* prognosis:
correlates to the depth of penetration into the
dermis. The 5-ys survival rate is 30%.
* superficial lesion radical local excision alone
with margins of 1 cm, is adequate.
* deeper lesions 1 mm or > radical local
excision + ipsilateral inguinal femoral
lymphadenectomy.
* adjuvant therapy:
= nonspecific immuno stimulants.
= chemotherapy.
= vaccines.
Thank You
Thank You
Ad

Recommended

Cancer of vulva
Cancer of vulva
drmcbansal
gynaecology.Vulval and vaginal benign and malignant conditions.(dr.mahabat)
gynaecology.Vulval and vaginal benign and malignant conditions.(dr.mahabat)
student
Vulva
Vulva
sailakshmidaayana
Carcinoma Vulva
Carcinoma Vulva
drmcbansal
Diseases of vulva
Diseases of vulva
Dr. Aisha M Elbareg
Vulval Cancer Diagnosis and Staging
Vulval Cancer Diagnosis and Staging
Dr.Bhavin Vadodariya
carcinoma vulva
carcinoma vulva
Karl Daniel, M.D.
VULVAR CARCINOMA - staging and stagewise management Layers and Pouches of the...
VULVAR CARCINOMA - staging and stagewise management Layers and Pouches of the...
ShubhamSinghChouhan6
Gynecology 5th year, 8th & 9th lectures (Dr. Muhabat Salih Saeid)
Gynecology 5th year, 8th & 9th lectures (Dr. Muhabat Salih Saeid)
College of Medicine, Sulaymaniyah
Cancers of vulva & vagina.pptx
Cancers of vulva & vagina.pptx
HrishikeshNPanicker
C8_1_27 (1).ppt PRECANCEROUS NAD MALIGNANT DISEASE OF VULVA
C8_1_27 (1).ppt PRECANCEROUS NAD MALIGNANT DISEASE OF VULVA
rishisingh823224
Vulval ca and vulval lymph
Vulval ca and vulval lymph
hemnathsubedii
vulva and vaginal cancers by Basira.pptx
vulva and vaginal cancers by Basira.pptx
Azadov1
Vulva ca sep course quick revision 2012
Vulva ca sep course quick revision 2012
Tariq Mohammed
vulval cancer
vulval cancer
DrDivyaShivanandShan
Carcinoma VULVA
Carcinoma VULVA
UJJWALKHULLAR
Vulval cancer
Vulval cancer
Hashem Yaseen
Condition affecting
Condition affecting
Magda Helmi
Lower genital tract tumors
Lower genital tract tumors
nahla humadi
42_Benign_and_Malignant_Conditions_of_the_Vulva_&_Vagina.pptx
42_Benign_and_Malignant_Conditions_of_the_Vulva_&_Vagina.pptx
Anane9
benign and malignant vulvar diseases.pptx
benign and malignant vulvar diseases.pptx
drparulanand
Dr Ayman Ewies - Vulvar Colposcopy 2009
Dr Ayman Ewies - Vulvar Colposcopy 2009
AymanEwies
Vulva disease
Vulva disease
Tariq Mohammed
Ca Vulva: Recapitulating the facts
Ca Vulva: Recapitulating the facts
Dr. Sunaina Wadhwa
c1 5th cycle lecture.pptxhdgsihdbdbhzkz
c1 5th cycle lecture.pptxhdgsihdbdbhzkz
chabsidarbi
DISEASES OF VULVA -BENIGN AND MALIGNANT
DISEASES OF VULVA -BENIGN AND MALIGNANT
Sagarika Majumdar
FEMALE GENITAL SYSTEM PATHOLOGY
FEMALE GENITAL SYSTEM PATHOLOGY
Dr. Roopam Jain
Vulvar cancer report
Vulvar cancer report
Sharmaine Florig
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
amitarathore081986
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Sajini

More Related Content

Similar to benign and malignant lesions Of-The-Vulva.ppt (20)

Gynecology 5th year, 8th & 9th lectures (Dr. Muhabat Salih Saeid)
Gynecology 5th year, 8th & 9th lectures (Dr. Muhabat Salih Saeid)
College of Medicine, Sulaymaniyah
Cancers of vulva & vagina.pptx
Cancers of vulva & vagina.pptx
HrishikeshNPanicker
C8_1_27 (1).ppt PRECANCEROUS NAD MALIGNANT DISEASE OF VULVA
C8_1_27 (1).ppt PRECANCEROUS NAD MALIGNANT DISEASE OF VULVA
rishisingh823224
Vulval ca and vulval lymph
Vulval ca and vulval lymph
hemnathsubedii
vulva and vaginal cancers by Basira.pptx
vulva and vaginal cancers by Basira.pptx
Azadov1
Vulva ca sep course quick revision 2012
Vulva ca sep course quick revision 2012
Tariq Mohammed
vulval cancer
vulval cancer
DrDivyaShivanandShan
Carcinoma VULVA
Carcinoma VULVA
UJJWALKHULLAR
Vulval cancer
Vulval cancer
Hashem Yaseen
Condition affecting
Condition affecting
Magda Helmi
Lower genital tract tumors
Lower genital tract tumors
nahla humadi
42_Benign_and_Malignant_Conditions_of_the_Vulva_&_Vagina.pptx
42_Benign_and_Malignant_Conditions_of_the_Vulva_&_Vagina.pptx
Anane9
benign and malignant vulvar diseases.pptx
benign and malignant vulvar diseases.pptx
drparulanand
Dr Ayman Ewies - Vulvar Colposcopy 2009
Dr Ayman Ewies - Vulvar Colposcopy 2009
AymanEwies
Vulva disease
Vulva disease
Tariq Mohammed
Ca Vulva: Recapitulating the facts
Ca Vulva: Recapitulating the facts
Dr. Sunaina Wadhwa
c1 5th cycle lecture.pptxhdgsihdbdbhzkz
c1 5th cycle lecture.pptxhdgsihdbdbhzkz
chabsidarbi
DISEASES OF VULVA -BENIGN AND MALIGNANT
DISEASES OF VULVA -BENIGN AND MALIGNANT
Sagarika Majumdar
FEMALE GENITAL SYSTEM PATHOLOGY
FEMALE GENITAL SYSTEM PATHOLOGY
Dr. Roopam Jain
Vulvar cancer report
Vulvar cancer report
Sharmaine Florig
Gynecology 5th year, 8th & 9th lectures (Dr. Muhabat Salih Saeid)
Gynecology 5th year, 8th & 9th lectures (Dr. Muhabat Salih Saeid)
College of Medicine, Sulaymaniyah
Cancers of vulva & vagina.pptx
Cancers of vulva & vagina.pptx
HrishikeshNPanicker
C8_1_27 (1).ppt PRECANCEROUS NAD MALIGNANT DISEASE OF VULVA
C8_1_27 (1).ppt PRECANCEROUS NAD MALIGNANT DISEASE OF VULVA
rishisingh823224
Vulval ca and vulval lymph
Vulval ca and vulval lymph
hemnathsubedii
vulva and vaginal cancers by Basira.pptx
vulva and vaginal cancers by Basira.pptx
Azadov1
Vulva ca sep course quick revision 2012
Vulva ca sep course quick revision 2012
Tariq Mohammed
Condition affecting
Condition affecting
Magda Helmi
Lower genital tract tumors
Lower genital tract tumors
nahla humadi
42_Benign_and_Malignant_Conditions_of_the_Vulva_&_Vagina.pptx
42_Benign_and_Malignant_Conditions_of_the_Vulva_&_Vagina.pptx
Anane9
benign and malignant vulvar diseases.pptx
benign and malignant vulvar diseases.pptx
drparulanand
Dr Ayman Ewies - Vulvar Colposcopy 2009
Dr Ayman Ewies - Vulvar Colposcopy 2009
AymanEwies
Ca Vulva: Recapitulating the facts
Ca Vulva: Recapitulating the facts
Dr. Sunaina Wadhwa
c1 5th cycle lecture.pptxhdgsihdbdbhzkz
c1 5th cycle lecture.pptxhdgsihdbdbhzkz
chabsidarbi
DISEASES OF VULVA -BENIGN AND MALIGNANT
DISEASES OF VULVA -BENIGN AND MALIGNANT
Sagarika Majumdar
FEMALE GENITAL SYSTEM PATHOLOGY
FEMALE GENITAL SYSTEM PATHOLOGY
Dr. Roopam Jain

Recently uploaded (20)

JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
amitarathore081986
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Sajini
5-Lift Analysis in ergonomics focuses on evaluating the safety and efficienc...
5-Lift Analysis in ergonomics focuses on evaluating the safety and efficienc...
Bolan University of Medical and Health Sciences ,Quetta
NEW dental implant design [Autosaved].pptx
NEW dental implant design [Autosaved].pptx
Nehal mohamed
Biography and Professional Career of Dr. Seth Eidemiller
Biography and Professional Career of Dr. Seth Eidemiller
Dr. Seth Eidemiller
Theories of Learning and Teaching.......
Theories of Learning and Teaching.......
Avantika Gupta
Clinical Signs Overview: PICCKLE Mnemonic
Clinical Signs Overview: PICCKLE Mnemonic
Dr Aman Suresh Tharayil
Ratricharya according to ayurveda along with day and night pattern in various...
Ratricharya according to ayurveda along with day and night pattern in various...
DR DHARMENDRA BINJHWAR
GAIT in Biomechanics along with abnormal gait
GAIT in Biomechanics along with abnormal gait
Nerusu sai priyanka
ELECTROMYOGRAPHY.pptX by GOKULAKRISHNAN.
ELECTROMYOGRAPHY.pptX by GOKULAKRISHNAN.
GOKULAKRISHNAN JANARTHANAN
DETAILS ABOUT THE Eicosanoids .pptx
DETAILS ABOUT THE Eicosanoids .pptx
PackialakshmiP
State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?
Duke Heart
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
nihalanichz
Abnormal Uterine Bleeding and its Management
Abnormal Uterine Bleeding and its Management
Chandrika Kulkarni
Growth hormone by Dr Kondam AmbareeshaGoud
Growth hormone by Dr Kondam AmbareeshaGoud
Dr K Ambareesha Goud PhD
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
Tina Purnat
HEMOLYTIC ANEMIA - thalassemia, AIHA, and NACP
HEMOLYTIC ANEMIA - thalassemia, AIHA, and NACP
SSIMS & RC
Day care surgery anaesthesia and management of complications in postoperative...
Day care surgery anaesthesia and management of complications in postoperative...
deepika582423
Unlocking the Potential of Long-Acting PrEP to Halt HIV Transmissions
Unlocking the Potential of Long-Acting PrEP to Halt HIV Transmissions
PVI, PeerView Institute for Medical Education
Coarse Dispersion, Physical Pharmaceutics
Coarse Dispersion, Physical Pharmaceutics
nishiprakashj
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
JAUNDICE,BIOCHEMISTRY, FIRST MBBS STUDENTS
amitarathore081986
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Drugs Acting on the Autonomic Nervous System Classification, Properties & Uses
Sajini
NEW dental implant design [Autosaved].pptx
NEW dental implant design [Autosaved].pptx
Nehal mohamed
Biography and Professional Career of Dr. Seth Eidemiller
Biography and Professional Career of Dr. Seth Eidemiller
Dr. Seth Eidemiller
Theories of Learning and Teaching.......
Theories of Learning and Teaching.......
Avantika Gupta
Clinical Signs Overview: PICCKLE Mnemonic
Clinical Signs Overview: PICCKLE Mnemonic
Dr Aman Suresh Tharayil
Ratricharya according to ayurveda along with day and night pattern in various...
Ratricharya according to ayurveda along with day and night pattern in various...
DR DHARMENDRA BINJHWAR
GAIT in Biomechanics along with abnormal gait
GAIT in Biomechanics along with abnormal gait
Nerusu sai priyanka
DETAILS ABOUT THE Eicosanoids .pptx
DETAILS ABOUT THE Eicosanoids .pptx
PackialakshmiP
State of the Art LVAD Care: What Does the Year 2025 Bring?
State of the Art LVAD Care: What Does the Year 2025 Bring?
Duke Heart
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
THE EYELID PPT FOR 1ST YEAR BSC OPTOMETRY
nihalanichz
Abnormal Uterine Bleeding and its Management
Abnormal Uterine Bleeding and its Management
Chandrika Kulkarni
Growth hormone by Dr Kondam AmbareeshaGoud
Growth hormone by Dr Kondam AmbareeshaGoud
Dr K Ambareesha Goud PhD
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
REFRAMING OF EXPERTISE AND INFORMATION IN HEALTH
Tina Purnat
HEMOLYTIC ANEMIA - thalassemia, AIHA, and NACP
HEMOLYTIC ANEMIA - thalassemia, AIHA, and NACP
SSIMS & RC
Day care surgery anaesthesia and management of complications in postoperative...
Day care surgery anaesthesia and management of complications in postoperative...
deepika582423
Coarse Dispersion, Physical Pharmaceutics
Coarse Dispersion, Physical Pharmaceutics
nishiprakashj
Ad

benign and malignant lesions Of-The-Vulva.ppt

  • 1. Diseases of the Vulva Diseases of the Vulva Azza Alyamani Azza Alyamani Department Department of of Obstet. & Gynecol. Obstet. & Gynecol.
  • 2. Vulvo-vaginal problems are among 10 leading disorders encountered by primary care clinicians. * Benign lesions of the vulva are mentioned in three categories : 1. Epithelial conditions. 2. Benign neoplastic disorders. 3. Dermatologic disorders. * VIN * Cancer vulva
  • 4. (1) Epithelial Conditions 1) Lichen simplex . 2) Lichen sclerosis. 3) Lichen planus, erosive lichen planus.
  • 5. 1) Lichen Simplex squamous cell hyperplasia * it is a local thickening of the epithelium resulting from a prolonged itching . * symptoms : pruritus and pain. * signs : white or reddish thickened ,leathery ,raised surface. usually discrete lesion but may be multiple. * treatment : moderate-strength steroid ointment. antipruritic agent.
  • 7. 2) Lichen Sclerosis * it is a chronic progressive disease which constrict and destroy the normal genital anatomy . In the long term ,labia minora are lost ,labia majora flatten ,clitoris becomes inverted . * frequently found on the vulva of postmenopausal women & can involve all the genital area from mons to the anal area.
  • 8. * combinations of lichen sclerosis & epithleal hyperplasia or carcinoma are possible. * symptoms: intense pruritus , dyspareunia and burning pain. * signs: thin inelastic atrophic skin ,white with a crinkled , tissue paper appearance.
  • 9. * diagnosis: multiple biopsies is necessary. it reveals a thin atrophic epithelium with inflammatory cells lining the basement membrane. * treatment: potent topical steroids. 80% of lesions respond. long term therapy with low potent steroids may be necessary. other local treatments are: esrtogen cream and anaesthetics.
  • 11. 3) Lichen planus * it is a purplish ,polygonal papules that may appear in their erosive form. * it involve the vulva ,the vagina and the mouth ( vulval vaginal gingival syndrome ). * symptoms: vulval burning , severe dyspareunia when vaginal stenosis develop in advanced stages. * treatment: topical and systemic steroids .
  • 12. erosive lichen planus lichen planus of vulva & vagina
  • 13. (2) Benign Neoplastic condions 1) epidermal inclusion and sebaceous cysts. 2) vulvar varicosities. 3) fibromas and lipomas. 4) clitoromegaly.
  • 14. 1) epidermal inclusion & sebaceous cysts * they are nontender , mobile , spherical ,slow growing cysts located below the epidermis. * sebaceous cysts are firmer bec. they are filled with dry caseous material. * treatment : most of inclusion cysts require no ttt. if they are asymptomatic, or surgical excision.
  • 15. 2) Vulval Varicosities Can enlarge especially during pregnancy to cause discomfort and carry a possible risks for rupture or thrombosis.
  • 16. 3) Fibromas and Lipomas Fibromas: * are the most common benign solid tumors that arise in the deeper connective tissue of the vulva. * they are slow growing 110 cm in diameter, but may become huge . Lipomas: * slow growing tumors composed of adipose cells.
  • 18. 4) Clitoromegaly * may develop after birth in response to excessive androgen exposure . It is a sign virillization. * diagnosed when the clitorial length exceeds 30 mm or the width at the base exceeds 10 mm.
  • 20. ( 3) Dermatologic Disorders 1) Psoriasis. 2) Behcet s syndrome. 3) Crohn s disease . 4) Acanthosis nigricans .
  • 21. 1) Psoriasis appears velvety but lack the characteristic scaly patches found on the knees & elbows.
  • 22. 2) Behcet s syndrome * ulcers in the vulval , oral and ocular areas. * genital lesions can result over time in a scarred vulva. * etiology : is unknown. * diagnosis : based on the concurrence ulcers in vulva ,mouth & ocular involvement ,the recurrent nature of the disease and exclusion of syphilis and Crohns disease. * treatment : no effective ttt.
  • 23. oral ulcer vulvar ulcer Behcet s disease
  • 24. 3) Crohns disease * vulval ulcers can precede the development of GIT ulcerations . * vulval ulcers are slit-like or knife cut ulcers with prominent edema. Draining sinuses and fistulas to the rectum may occur.
  • 25. 4) Acanthosis nigricans * most commonly found in the axilla or the nape of the neck then vulva. * characterized by its darky pigmented velvety or warty surface . * etiology : related to insulin resistance.
  • 26. Vulval Neoplasms Introduction * uncommon 5 % of female genital tract malign. most tumors are squamous cell carcinomas ,may be melanomas , adenocarcinomas and sarcomas. * postmenopausal women ,mean age 65 years. * a history of chronic vulval itching is common.
  • 27. Epidemiology Two different etiologic types of vulval cancers : 1. A less common type: * in younger women . * related to HPV infection and smoking. * commonly associated with VIN .
  • 28. 2. The more common type: * in old women . * unrelated to HPV infection or smoking. * concurrent VIN is uncommon. * long standing lichen sclerosis is common. 5% of patients have +ve serologic tests for syphilis , lymphogranuloma venereum and granuloma inguinale.
  • 29. Vulval Intraepithelial Neoplasia (VIN) 2 types of VIN : 1. squamous cell carcinoma in situ VIN III or Bowens disease. 2. Adenocarcinoma in situ VIN III or Pagets disease.
  • 30. Squamous cell carcinoma in situ: VIN III ( Bowens disease ) * mean age 45 years. * symptoms: 50% asymptomatic. itching is the most common symptom. * signs: most lesions are elevated ,white ,red ,pink , brown or grey in color. 20% of lesions are warty in appearance.
  • 31. * diagnosis: 1.careful inspection of the vulva in bright light and with the aid of a magnifying glass. 2. 5% acetic acid aceto white areas.
  • 32. * treatment : 1. local superficial excision. with margins of 5 mm are adequate. 2. skinning vulvectomy in extensive lesions. 3. laser therapy if lesions involves the clitoris , labia minora or perineal area.
  • 33. Adenocarcinoma in situ VIN III ( Paget s disease ) * occurs in white postmenopausal elderly women. also occurs in the nipple area of the breast. * 20% is associated with adenocarcinoma. * symptoms: itching and tenderness are common. * signs: well demarcated and eczematus with white plaque like lesions. * growth may progresses beyond the vulva to the mons pubis ,buttocks & thighs.
  • 34. * diagnosis histologically: adenocarcinoma in situ characterized by large ,pale , pathognomonic Paget s cells, typically located both in the epidermic and in the adnexal structures. * treatment: 1. local superficial excision. with margins 5-10 mm. 2. laser therapy in recurrences which are common.
  • 36. Invasive Cancer Vulva A. Squamous cell carcinoma * 90% of vulval cancers. * symptoms: vulval lump or ulcer. long standing pruritus. * signs: raised ,ulcerated ,pigmented or warty lesion. however , ulceration is usually an early sign. most lesions occur on labia majora and labia minora. Less common sites , the clitoris or the perineum. 5% of lesions are multifocal.
  • 38. * spread : direct extension to adjacent structures as the vagina , urethra and anus. lymphatic embolisation inguino femoral nodes. = initially to the superficial inguinal LN. = then to deep femoral LN. located medial to the femoral vein, LN of Cloquets is the most common of this group. =then spread occurs to pelvic nodes especially the external iliac LN.
  • 39. = LN metastases occurs 50% in cancer vulva. 5% of patients have metastases to pelvic LN , usually 3 or more +ve unilateral inguino femoral LN. hematogenous occurs late to the lungs , liver and bone rarely in the absence of lymphatic metastases.
  • 40. FIGO Staging of Cancer Vulva Stage I Ia Ib Stage II Stage III Tumor limited to the vulva or perineum or both ,and 2 cm or < in diameter ,and no nodal metastases. as above + stromal invasion < 1mm. as above + stromal invasion > 1 mm. Tumor limited to the vulva or perineum or both ,and > 2 cm in diameter ,and no nodal metastases. Tumor of any size with : adjacent spread to the urethra &/or vagina &/or anus unilateral regional LN. metastasis or combination.
  • 41. Stage IV IVa IVb Tumor invades any of the following pelvic : upper urethra ,bladder mucosa ,rectal mucosa ,pelvic bone or bilateral regional node metastasis ,or a combination. Any distant metastasis including pelvic lymph nodes.
  • 42. Management A) Early vulval cancer * Stage I a ( penetration depth < 1mm below the basement membrane & no nodal metastases ) radical local excision 辿 surgical margins 1cm, patient do not need groin dissection. * Stage I b & Stage II ( penetration > 1mm ) radical local excision +ipsilateral inguinal femoral lymphadenectomy if the lesion is unilateral and bilateral groin dissection in the midline lesions .
  • 43. B) Advanced vulval cancer * Stage III ( involves the proximal urethra ,anus or rectovaginal septum ) radical vulvectomy which includes a bowel, urinary stroma or rectovaginal septum. + bilateral groin dissection. Preoperative radiation or chemo-radiation should be used to shrink the 1ry tumor ,followed by more conservative surgical excision.
  • 44. C) Positive lymph nodes Radiation used with > one nodal mico metastasis (<5mm), or evidence of extra nodal spread . postoperative radiation to both groins and to the pelvis. Prognosis: = it correlate significantly with LN status. with ve nodes have a 5-ys survival rate is 90%. with +ve nodes have a 5-ys survival rate is 50%. = patient with no involved node have a good prognosis regardless of stage.
  • 45. Malignant Melanoma * the 2nd most common vulvar cancer. * may arise de novo or from a preexisting nevus. commonly involve labia minora or clitoris. * occurs in postmenopausal white women. * diagnosis : any pigmented lesion of the vulva requires excisional biopsy for histopathology. * usually smaller lesions and tend to metastasized early.
  • 47. * prognosis: correlates to the depth of penetration into the dermis. The 5-ys survival rate is 30%. * superficial lesion radical local excision alone with margins of 1 cm, is adequate. * deeper lesions 1 mm or > radical local excision + ipsilateral inguinal femoral lymphadenectomy. * adjuvant therapy: = nonspecific immuno stimulants. = chemotherapy. = vaccines.